4 Seniors & Aging Demographics Stocks to Watch Right Now
ABBV, AMGN, SYK and DXCM are well-poised to benefit from the evolving new opportunities in Seniors & Aging Demographics within healthcare.
PMLiVE4d
AbbVie and Xilio announce immunotherapy partnership worth over $2.1bn
AbbVie and Xilio Therapeutics have announced a partnership worth over $2.1bn to develop tumour-activated, antibody-based immunotherapies. The collaboration and option-to-licence agreement will include ...
MM&M8d
Rx Rundown: Novartis, Abcuro, SpringWorks Therapeutics and more
RxTechExam and the Pennsylvania Pharmacists Association announced a strategic partnership. Roche’s $8 billion InterMune acquisition has been handed to a specialty pharmaceutical company, Cayman ...
Pharmaceutical Technology8d
AbbVie and Xilio to collaborate on antibody-based immunotherapies
AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...
Wall Street Today: Dow Jones drops 400 points as US Inflation rises 50 bps to 3% YoY, dimming hopes for Fed rate cuts
The Dow Jones index dropped 400 points on Wednesday, February 12 as US Inflation data dimmed Federal Reserve rate cuts hopes ...
BioWorld9d
Xilio advances masked T-cell engagers targeting PSMA, CLDN18.2 and STEAP1
Xilio Therapeutics Inc. has announced three wholly owned preclinical programs for masked T-cell engagers targeting prostate-specific membrane antigen (PSMA), claudin 18.2 (CLDN18.2) and ...
Xilio (XLO) Stock Zooms 125% Higher On Cancer Fighting Deal with AbbVie
Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie ...